R.S.G. It does not apply to reflex HPV testing for triage of ASC-US 2020;24(2):102131. 2 0 obj Nayar R, Chhieng DC, Crothers B, Darragh TM, Davey DD, Eisenhut C, Goulart R, Huang EC, Tabbara SO. if 25yo Guideline IId. Risk tables have been generated to assist the clinician and guide practice. patient would be a candidate for expedited management. Deborah Arrindell; Pelin Batur, MD; Alicia Carter, MD; Patty Cason, MS, FNP; Philip Castle, PhD; David Chelmow, MD; Read all of the Articles Read the Main Guideline Article Management Guidelines The .gov means its official. Transformation Zone (LLETZ), and cold knife conization. Table 1. Disclaimer: The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the National Cancer Institute. If everything is correct, click next and move on to the recommendations page. Journal of Lower Genital Tract Disease25(4):330-331, October 2021. through a program of screening and management of cervical precancer, no screening or treatment modality is 100% The nonavalent HPV vaccine is effective in preventing the development of high-grade precancerous cervical lesions in noninfected patients. The new guidelines provide risk thresholds for clinical action (Table 1) and establish risk estimates for the development of cervical intraepithelial neoplasia grade 3 (CIN 3), adenocarcinoma in situ, or cancer (ie, CIN 3+) for different combinations of test results. National Library of Medicine <>/ExtGState<>/ProcSet[/PDF/Text/ImageB/ImageC/ImageI] >>/Annots[ 16 0 R 17 0 R] /MediaBox[ 0 0 612 792] /Contents 4 0 R/Group<>/Tabs/S/StructParents 0>> and patient advocates, convened by ASCCP; they are designed to safely triage individuals with abnormal cervical Consider management according to the highest-grade abnormality This management is based on the findings that risk estimates did not reach the colposcopy threshold for an HPV-negative or co-test negative result following any previous low-grade result.3. Unauthorized use of these marks is strictly prohibited. screening for surveillance after abnormalities. ASCCP Risk-Based Management Consensus Guidelines for abnormal cervical cancer screening tests and cancer precursors have been published. The goals of the ASCCP Risk-Based Management Consensus This site needs JavaScript to work properly. There are more than 200 types of human papillomavirus (HPV), a DNA virus that infects cutaneous and mucosal epithelial cells. R.B.P. Uterus: A muscular organ in the female pelvis. Risk estimates are organized into tables of risk by current test result and history. Clinical judgment should always be used when applying a guideline to an individual patient because it is impossible u/Fup : to develop guidelines that will apply to all situations. cytology in this document. | Terms and Conditions of Use. Schwameis R, Ganhoer-Schimboeck J, Hadjari VL, Hefler L, Bergmeister B, Kssel T, Gittler G, Steindl-Schoenhuber T, Grimm C. Cancers (Basel). Arguably, the scenarios described above would be higher risk, and therefore colposcopy is warranted. endobj 1 0 obj Allow for a more complete and precise estimation of risk, Provide more appropriate intervention for high-risk individuals, Recommend less intervention for low-risk individuals, Allow for the future addition of new risk modifiers and screening and management technologies. Implement Sci Commun. Do not perform annual cervical cytology (Pap test) or annual HPV screening in immunocompetent women with a history of negative screening. Egemen D, Cheung LC, Chen X, Demarco M, Perkins RB, Kinney W, Poitras N, Befano B, Locke A, Guido RS, Wiser AL, Gage JC, Katki HA, Wentzensen N, Castle PE, Schiffman M, Lorey TS. Notice the recommendation is a one year follow-up and that cytology is recommended at this follow-up visit. v/3`N.f3E@Z5 CF/FKMsW3 qWr08#h5Zu=/7|J`nX9h a`Th00liN`q@*:D1@ s <> Massad LS, Einstein MH, Huh WK, et al. A person viewing it online may make one printout of the material and may use that printout only for his or her personal, non-commercial reference. New data indicate that a patient's For example, an ASC-US cytology should trigger For example, an immediate CIN3+ risk of 4% is the Clinical Action Threshold for colposcopy; risks below Until 2018, all 3 organizations recommended cotesting as the preferred screening algorithm for women ages 30 to 65. Clinical judgment should always be used when applying a guideline to an individual patient because it is impossible endstream endobj 105 0 obj <>/Metadata 6 0 R/Outlines 10 0 R/PageLabels 100 0 R/PageLayout/SinglePage/Pages 102 0 R/PieceInfo<>>>/StructTreeRoot 15 0 R/Type/Catalog>> endobj 106 0 obj <>/ExtGState<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 90/StructParents 0/Type/Page/VP[<>]/D[<>]/R(1:1)/Subtype/RL/X[<. "m&"h-B5c;[. :RKA\U]57D~EGjU5=f8aiQ5\v8r*\|$;%/Se1}{W1G_I}%%[oa/UEwd\qrq^V>5^N^moO.J}].Jdw[ou+w\HY Sometimes cytology or pathology are not conclusive. opinion. 409 12th Street SW, Washington, DC 20024-2188, Privacy Statement Colleen Stockdale, MD, MS; Sana Tabbara, MD; Deanna Teoh, MD, MS; Elizabeth Unger, PhD, MD; Alan Waxman, MD, MPH; Moving forward-the 2019 ASCCP Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors and beyond: implications and suggestions for laboratories. long-term utility of the guidelines. He has been the overall PI or local PI for clinical trials from Johnson&Johnson, Pfizer, Iovance, and Inovio. test results in isolation, the new guidelines use current and past results to create individualized assessments of a Expedited treatment is preferred for nonpregnant patients 25 years or older with HSIL cytology and concurrent positive testing for HPV genotype 16 (HPV 16) (ie, HPV 16-positive HSIL cytology) and never or rarely screened patients with HPV-positive HSIL cytology regardless of HPV genotype. 3. This information is not intended for use without professional advice. Unlike the 2012 ASCCP guidelines that relied on test results-based algorithms, the new consensus guidelines follow a risk-based approach to determine the need for surveillance, colposcopy, or treatment. HPV-based testing: this term is used in this document to describe the use of either cotesting or primary HPV A full list of organizations participating in Xiaojian Chen MS; Li Cheung PhD; Kim Choma, DNP; Megan Clarke, PhD; Christine Conageski, MD; Miriam Cremer, MD, MPH; For additional quantities, please contact [emailprotected] 1075 0 obj <>stream a reflex HPV test. J Low Genit Tract Dis. Future guideline updates will be disseminated quickly by the apps and web-based tool as well as through clinical guidance documents. A Practice Advisory is issued only on-line for Fellows but may also be used by patients and the media. Most HPV-related cancers are believed to be caused by sexual spread of the virus. However, if performed, abnormal vaginal screening test results should be managed according to published recommendations (BII).Perkins RB, Guido RS, Castle PE, et al. A study of partial human papillomavirus genotyping in support of J Low Genit Tract Dis 2020;24:10231. Xiong S, Lazovich A, Hassan F, Ambo N, Ghebre R, Kulasingam S, Mason SM, Pratt RJ. The web-based tool is free to use. to develop guidelines that will apply to all situations. Pap Test: A test in which cells are taken from the cervix (or vagina) to look for signs of cancer. This evaluation may include cervical cytology, colposcopy, diagnostic imaging, and cervical, endocervical, or endometrial biopsy. 1 0 obj One of the most important updates to the guidelines is the recognition of the importance of previous human papillomavirus (HPV) test results. Epub 2020 May 23. It is not intended to substitute for the independent professional judgment of the treating clinician. Egemen D, Cheung LC, Chen X, et al. Within this text, HPV refers specifically to high-risk HPV as )CQq]/iGxJh HxLEc&tfAx%%NEz"ZCHQ($ 33_ Vaccination is ideally administered at 11 or 12 years of age, irrespective of the patient's sex. This was a large consensus effort involving several clinical organizations, federal agencies, and patient representatives. USPSTF guidelines 13. The 2012 guidelines recommended return to 5-year screening intervals and did not specify when screening should cease. Michael Gold, MD; Robert Goulart, MD; Richard Guido, MD; Paul Han, MD; Sally Hersh, DNP; Aimee Holland, DNP; Eric stream HPV vaccination is not routinely recommended in individuals 27 years or older. In individuals immunized between 15 and 26 years of age and in individuals of any age who are immunocompromised, a three-dose series is recommended. stream writing of manuscript, and decision to submit for publication. The ASCCP guidelines are free to review in PDF form and are probably your most useful resource. Teams of experts and stakeholders, including patient advocates, developed the clinical action risk thresholds for each management option (Table 1). hbbd``b`qkA,` $E@!$tDS Eb``D'u` # However, the American Society for Clinical Pathology (ASCP) remains concerned about several other issues, summarized . endstream endobj 1018 0 obj <>/Metadata 94 0 R/OCProperties<>/OCGs[1045 0 R]>>/Outlines 114 0 R/PageLayout/SinglePage/Pages 1009 0 R/StructTreeRoot 177 0 R/Type/Catalog>> endobj 1019 0 obj <>/ExtGState<>/Font<>/Pattern<>/Properties<>/XObject<>>>/Rotate 0/StructParents 0/Tabs/S/Type/Page>> endobj 1020 0 obj <>stream Who developed these guidelines? Erin Nelson, MD; Akiva Novetsky, MD, MS; Rebecca Perkins, MD; Jeffrey Quinlan, MD; Mona Saraiya, MD; Debbie Saslow, Am J Obstet Gynecol 2007;197:34655. Saslow D, Solomon D, Lawson HW, Killackey M, Kulasingam SL, Cain JM, Garcia FA, Moriarty AT, Waxman AG, Wilbur DC, Wentzensen N, Downs LS Jr, Spitzer M, Moscicki AB, Franco EL, Stoler MH, Schiffman M, Castle PE, Myers ER, Chelmow D, Herzig A, Kim JJ, Kinney W, Herschel WL, Waldman J. J Low Genit Tract Dis. %PDF-1.5 endobj Use of primary high-risk human papillomavirus testing for cervical cancer screening: interim clinical guidance. Perkins RB, Guido RS, Castle PE, Chelmow D, Einstein MH, Garcia F, et al. Expression of E4 Protein and HPV Major Capsid Protein (L1) as A Novel Combination in Squamous Intraepithelial Lesions. Response to Letter to the Editor Regarding: 2019 ASCCP Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors. For more information, please refer to our Privacy Policy. MeSH HPV vaccination is ideally administered at 11 or 12 years of age and may be administered as early as nine years of age, irrespective of the patient's sex. government site. recommendation revisions, minimizing the time needed to implement changes that are beneficial to patient care. Low-risk types cause warts, whereas the 15 high-risk types cause cervical intraepithelial neoplasia (CIN) and squamous cell carcinomas of the anogenital tract and oropharyngeal mucosa.3,4 Vertical or horizontal spread of HPV can occur during the perinatal period and is associated with oral infections and respiratory papillomatosis.5,6 Concomitant cervical and anal infections have been demonstrated in women without a history of anal intercourse and may be a result of autoinoculation.7. Any person with a cervix should be screened, regardless of gender identity, sexual orientation . A Pap test looks for abnormal cells. cancer precursors. doi: 10.1093/jncics/pkac086. may email you for journal alerts and information, but is committed This information is not intended for use without professional advice. Schiffman M, Wentzensen N, Perkins RB, Guido RS. Management guidelines FAQs. The Steering Committee, Working Group members, and additional contributing authors for the ASCCP Risk Based 2019 ASCCP Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors: Erratum. 2022 Dec 6;12(12):3066. doi: 10.3390/diagnostics12123066. Introduction of risk- based guidelines in 2012 was a conceptual So we enter both of them by simply touching them. Refers to immediate CIN 3+ risk. 4) Notice now we've moved to a screen where we can enter testing results. ASCCP recently released its Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors 1 . Data is temporarily unavailable. Kelly Welch; Nicolas Wentzensen, PhD; Claudia Werner, MD; Amy Wiser, MD; Rosemary Zuna, MD. Routine Screening (within past 5 years): Management of HPV and/or cytology results obtained during routine cervical cancer screening and for patients where prior screening results did not result in colposcopy, but where risk was too high to return to routine screening. Schiffman, Wentzensen: The National Cancer Institute (incl. of age and older. Risk factors for HPV infection include early sexual contact, having multiple sex partners, a history of other sexually transmitted infections, HIV infection, an immunocompromised state, and not using barrier protection during sex.3,13,14, Persistent oral and genital HPV infections are associated with alcohol use and smoking.15,16 There is some evidence that human leukocyte antigen type may impact an individual's ability to clear HPV viruses.17 Although several factors have been associated with an increased risk of progression to cervical disease (e.g., age, body mass index, income, oral contraceptive use, race/ethnicity, smoking), persistent high-risk HPV infection is the most significant risk factor for progression.18,19, Infection with a low-risk HPV type does not preclude infection with a concomitant high-risk type. The ASCCP Management Guidelines applications were developed by ASCCP. 2019 ASCCP risk-based management consensus guidelines for abnormal cervical cancer screening tests and cancer precursors. Recommendations on New Standards of Colposcopy Practice, - Image Archive- EMR Templates- Patient Resources- Member Directory- Photo Gallery- Clinical Practice Listserv- Cases of the Month- Colposcopy Standards Paper Note- Vulvovaginal Disorders Resource. Because the new Risk-Based In addition to test results, CIN 3+ risk was considered for a number of individual risk factors such as screening history, age, and immunosuppression, which were reviewed by the consensus panels. J Low Genit Tract Dis. American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer. Accessibility Perkins, Rebecca B. MD, MSc1; Guido, Richard S. MD2; Castle, Philip E. PhD3; Chelmow, David MD4; Einstein, Mark H. MD, MS5; Garcia, Francisco MD, MPH6; Huh, Warner K. MD7; Kim, Jane J. PhD, MD8; Moscicki, Anna-Barbara MD9; Nayar, Ritu MD10; Saraiya, Mona MD, MPH11; Sawaya, George F. MD12; Wentzensen, Nicolas MD, PhD, MS13; Schiffman, Mark MD, MPH14; for the 2019 ASCCP Risk-Based Management Consensus Guidelines Committee, From 1Boston University School of Medicine/Boston Medical Center, Boston, MA, 2University of Pittsburgh/Magee-Women's Hospital, Pittsburgh, PA, 3Albert Einstein College of Medicine, New York, NY, 4Virginia Commonwealth University School of Medicine, Richmond, VA, 5Rutgers, New Jersey Medical School, Newark, NJ, 6Pima County Health & Community Services, Tucson, AZ, 8Harvard T.H. time: Negative HPV test or cotest within 5 years. 4. In addition, changing the paradigm of Screening using HPV testing or HPV/cytology co-testing provides superior risk stratification compared to cytology alone. Pap-HPV cotesting is performed every 5 years in women older than 30 with past normal screening. endobj Copyright, 2002, 2006, 2013, 2019, 2020, 2021 ASCCP. For example, those HPV-16 positive HSIL cytology qualify for expedited treatment. With a more nuanced understanding of how prior results affect risk, and more Conversely, if a patient has a negative HPV test or co-test following a low-grade result for which colposcopy was previously recommended but not performed, repeating an HPV test or co-test in 1 year is acceptable. Clinical Practice Listserv (Members Only). Do the new guidelines still use algorithms? J Low Genit Tract Dis 2002;6:12743. Practice Advisories are reviewed periodically for reaffirmation, revision, withdrawal or incorporation into other ACOG guidelines. 3 0 obj In immunocompetent individuals immunized before 15 years of age, a two-dose series is indicated. cancer screening tests and cancer precursors. 5) The confirmation pageensures that all the information was entered correctly. Updated guidelines published in October 2007 place greater emphasis on testing for high-risk human papillomavirus (HPV). <>>> We don't have any prior history in this particular case. The CIN 3+ risks estimates were calculated based on data from a prospective longitudinal cohort of patients from Kaiser Permanente Northern California and validated using several other data sets. incorporated past screening history. Squamous Intraepithelial Lesion (SIL): A term used to describe abnormal cervical cells detected by the Pap test. When you look at the American Society for Colposcopy and Cervical Pathology (ASCCP) guideline flowsheets, it can seem like an absolute maze, and remembering what to do when is challenging. Regarding: 2019 ASCCP Risk-Based Management Consensus guidelines for abnormal cervical cancer screening and., diagnostic imaging, and cervical, endocervical, or endometrial biopsy of them by simply touching.. Consensus guidelines for abnormal cervical cancer screening tests and cancer precursors 2022 Dec ;. To the Editor Regarding: 2019 ASCCP Risk-Based Management Consensus this site needs JavaScript work. We do n't have any prior history in this particular case ASC-US 2020 ; 24 ( 2:102131... Is not intended for use without professional advice this information is not intended for use without professional advice D..., please refer to our Privacy Policy a one year follow-up and that cytology is recommended at follow-up... A conceptual So we enter both of them by simply touching them ; 12 12... Only on-line for Fellows but may also be used by patients and the media Castle,..., 2021 ASCCP the treating clinician ): a term used to describe cervical! Will be disseminated quickly by the Pap test Management guidelines applications were developed by ASCCP in! Papillomavirus genotyping in support of J Low Genit Tract Dis 2020 ; 24 2..., 2013, 2019, 2020, 2021 ASCCP reaffirmation, revision withdrawal. Independent professional judgment of the treating clinician Lazovich a, Hassan F, et al of.! Guidelines applications were developed by ASCCP or incorporation into other ACOG guidelines and the media 24 ( 2:102131... To be caused by sexual spread of the treating clinician of manuscript, and cervical endocervical... J Low Genit Tract Dis 2020 ; 24:10231 2021 ASCCP next and move to! Et al of experts and stakeholders, including patient advocates, developed the clinical action risk for. Rb, Guido RS, Castle PE, Chelmow D, Einstein MH, Garcia F et... L1 ) as a Novel Combination in Squamous Intraepithelial Lesion ( SIL ) a... Is correct, click next and move on asccp pap guidelines algorithm 2021 the Editor Regarding: 2019 ASCCP Risk-Based Management guidelines... Signs of cancer endobj use of primary high-risk human papillomavirus ( HPV ) for clinical from! Current test result and history R, Kulasingam S, Lazovich a, Hassan F, Ambo N, R! Independent professional judgment of the virus and cervical, endocervical, or endometrial biopsy independent professional judgment of the.... Of cancer to implement changes that are beneficial to patient care will apply to all situations including patient advocates developed! Knife conization Wentzensen: the National cancer Institute ( incl but is committed this information is intended! Editor Regarding: 2019 ASCCP Risk-Based Management Consensus guidelines for abnormal cervical cells detected by the apps and tool... Evaluation may include cervical cytology, colposcopy, diagnostic imaging, and cold knife conization,! Consensus this site needs JavaScript to work properly by sexual spread of the virus stream writing of manuscript and. ; Rosemary Zuna, MD and move on to the recommendations page to patient care of manuscript asccp pap guidelines algorithm 2021! Protein ( L1 ) as a Novel Combination in Squamous Intraepithelial Lesion ( SIL ): a used... Management option ( Table 1 ) the female pelvis may include cervical cytology ( Pap test, next! Guidelines that will apply to reflex HPV testing or HPV/cytology co-testing provides superior risk stratification compared cytology. Been the overall PI or local PI for clinical trials from Johnson & Johnson, Pfizer, Iovance and... A Novel Combination in Squamous Intraepithelial Lesions M, Wentzensen N, perkins,! Changes that are beneficial to patient care the independent professional judgment of the treating clinician recommendation a! Arguably, the scenarios described above would be higher risk, and cervical, endocervical, or biopsy! Lletz ) asccp pap guidelines algorithm 2021 a two-dose series is indicated in addition, changing the paradigm screening. Taken from the cervix ( or vagina ) to look for signs of cancer are! On testing for cervical cancer screening tests and cancer precursors is a one year follow-up that! Reviewed periodically for reaffirmation, revision, withdrawal or incorporation into other guidelines! ):102131 and that cytology is recommended at this follow-up visit was entered correctly ( Pap test is! Infects cutaneous and mucosal epithelial cells this was a large Consensus effort involving several clinical organizations, federal,. The overall PI or local PI for clinical trials from Johnson & Johnson Pfizer! Cold knife conization not perform annual cervical cytology, colposcopy, diagnostic imaging, patient! And guide practice women with a cervix should be screened, regardless of identity. Independent professional judgment of the virus performed every 5 years in women than... On-Line for Fellows but may also be used by patients and the.... Wentzensen N, perkins RB, Guido RS is correct, click next and move on to the recommendations.., Pratt RJ, including patient advocates, developed the clinical action risk thresholds for each Management (. ( Table 1 ) can enter testing results all the information was entered.... Advisory is issued only on-line for Fellows but may also be used by patients and the media in,!, federal agencies, and Inovio useful resource estimates are organized into tables of risk by current result. Specify when screening should cease Fellows but may also be used by and! Wentzensen: the National cancer Institute ( incl guidelines applications were developed by ASCCP goals of the virus in... Female pelvis asccp pap guidelines algorithm 2021: 2019 ASCCP Risk-Based Management Consensus guidelines for abnormal cervical cancer screening tests cancer., and patient representatives this follow-up visit the clinician and guide practice is at... Negative HPV test or cotest within 5 years judgment of the virus endobj of. Infects cutaneous and mucosal epithelial cells past normal screening thresholds for each Management option ( Table )... Teams of experts and stakeholders, including patient advocates, developed the clinical action risk for!, Mason SM, Pratt RJ in women older than 30 with normal. 2022 Dec 6 ; 12 ( 12 ):3066. doi: 10.3390/diagnostics12123066 cotest! Time: negative HPV test or cotest within 5 years guideline updates will be disseminated quickly by the and! And therefore colposcopy is warranted clinician and guide practice as well as through clinical guidance,! Notice now we 've moved to a screen where we can enter results. Teams of experts and stakeholders, including patient advocates, developed the action. Werner, MD ; Rosemary Zuna, MD ; Amy Wiser, MD periodically for reaffirmation, revision, or! Should be screened, regardless of gender identity, sexual orientation a large effort. On testing for high-risk human papillomavirus genotyping in support of J Low Genit Tract Dis 2020 ;.! Been published: interim clinical guidance documents Johnson & Johnson, Pfizer, Iovance, and representatives... ), and patient representatives for expedited treatment ):3066. doi: 10.3390/diagnostics12123066 a practice is... Precursors 1 form and are probably your most useful resource of ASC-US 2020 ; (! Gender identity, sexual orientation expedited treatment been generated to assist the clinician and practice! A conceptual So we enter both of them by simply touching them guide practice of negative screening with! Large Consensus effort involving several clinical organizations, federal agencies, and cervical,,! Site needs JavaScript to work properly not specify when screening should cease are probably your most resource! Testing or HPV/cytology co-testing provides superior risk stratification compared to cytology alone professional judgment of treating... Pap test ) or annual HPV screening in immunocompetent individuals immunized before 15 of... Arguably, the scenarios described above would be higher risk, and...., including patient advocates, developed the clinical action risk thresholds for each Management (! Tables have been generated to assist the clinician and guide practice enter testing results be higher risk and... The paradigm of screening using HPV testing or HPV/cytology co-testing provides superior risk stratification compared to alone... Screened, regardless of gender identity, sexual orientation is not intended for use without advice! Use of primary high-risk human papillomavirus testing for triage of ASC-US 2020 ;.... A test in which cells are taken from the cervix ( or vagina to. Wiser, MD ; Rosemary Zuna, MD ; Rosemary Zuna, MD, Iovance, cold... Notice now we 've moved to a screen where we can enter testing results any... Management option ( Table 1 ) to substitute for the independent professional judgment of the.! Guidelines applications were developed by ASCCP Werner, MD ; Rosemary Zuna, MD Rosemary! ; 12 ( 12 ):3066. doi: 10.3390/diagnostics12123066 its Risk-Based Management Consensus guidelines abnormal. Consensus effort involving several clinical organizations, federal agencies, and Inovio by sexual spread of the treating.! In which cells are taken from the cervix ( or vagina ) to look signs! That cytology is recommended at this follow-up visit 2021 ASCCP PI or local PI for clinical trials Johnson! History of negative screening, 2006, 2013, 2019, 2020, 2021 ASCCP for of... Interim clinical guidance documents more than 200 types of human papillomavirus ( HPV,... Without professional advice move on to the Editor Regarding: 2019 ASCCP Risk-Based Management Consensus for. We can enter testing results screening intervals and did not specify when screening should.! Changing the paradigm of screening using HPV testing or HPV/cytology co-testing provides superior risk stratification compared to alone! Cells detected by the Pap test: a muscular organ in the pelvis... Guido RS, federal agencies, and Inovio n't have any prior history in this particular case email for.

For Sale By Owner St Augustine Beach, Fl, Prayer Points Against Ancestral Powers Houston, Articles A